Related Experiment Videos
Factors that control extravascular fibrinolysis
Seminars in Thrombosis and Hemostasis
|January 1, 1996
Summary
Extravascular fibrinolysis involves a balance between fibrinolytic enzymes and inhibitors, crucial for tissue repair and disease states. Understanding fibrin structure modification and factor binding offers insights into complex fibrinolysis regulation.
Area of Science:
- Biochemistry
- Physiology
- Molecular Biology
Background:
- Tissue states (inflammation, injury, malignancy) influence plasma protein exudation, hemostasis, and fibrinolysis.
- Extravascular fibrinolysis is regulated by the balance between fibrinolytic enzymes (e.g., plasmin) and their inhibitors (e.g., PAI-1).
- Fibrin structure, modified by factor XIIIa cross-linking and alpha 2-plasmin inhibitor binding, dictates its stability against proteolysis.
Purpose of the Study:
- To elucidate the biochemical controls governing extravascular fibrinolysis.
- To understand the role of fibrin structure modification in fibrinolysis regulation.
- To explore how factor binding to fibrinogen influences fibrinolytic reactions.
Main Methods:
- Analysis of the balance between fibrinolytic enzyme generation and inhibition.
- Investigation of factor XIIIa-mediated structural modifications of fibrin.
- Examination of the binding affinity of proenzymes (factor XIII, plasminogen) to fibrinogen.
- Assessment of agents affecting factor XIIIa activity and fibrin(ogen) binding.
Main Results:
- Fibrin structure modification, including cross-linking and alpha 2-plasmin inhibitor incorporation, enhances fibrin stability.
- Factor XIIIa activity is modulated by various agents like sulfhydryl compounds and albumin.
- Proenzymes factor XIII and plasminogen exhibit high affinity for fibrinogen, ensuring reaction specificity and governing fibrinolysis kinetics.
- Interference with these binding reactions, such as by autoantibodies, can impact fibrinolytic processes.
Conclusions:
- The intricate regulation of extravascular fibrinolysis relies on the interplay between fibrin structure, enzyme-inhibitor balance, and specific factor-fibrinogen interactions.
- Understanding these biochemical mechanisms provides critical insights into pathological conditions involving aberrant fibrinolysis.
- Targeting these regulatory pathways may offer therapeutic strategies for diseases associated with inflammation, injury, and malignancy.